1. A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265). Issue 2 (December 2015) Authors: Long, Georgina; Dummer, Reinhard; Ribas, Antoni; Puzanov, Igor; Michielin, Olivier; VanderWalde, Ari; Andtbacka, Robert; Cebon, Jonathan; Fernandez, Eugenio; Malvehy, Josep; Olszanski, Anthony; Gajewski, Thomas; Kirkwood, John; Kuznetsova, Olga; Chen, Lisa; Kaufman, David; Chou, Jeffrey; Hodi, F Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in patients (pts) at high risk for recurrence. Issue 2 (December 2015) Authors: Weber, Jeffrey; Grob, Jean-Jaques; Margolin, Kim; Ascierto, Paolo; Sznol, Mario; Ott, Patrick; Lejeune, Chantal; de Pril, Veerle; Ruisi, Mary; Hodi, F Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI). Issue 2 (December 2015) Authors: Bartell, Heddy; Wolchok, Jedd; Hodi, F; Liu, Helen; Wojtaszek, Cynthia; Weber, Jeffrey Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunologic profiling of adenoid cystic carcinoma (acc). Issue 2 (December 2015) Authors: Sridharan, Vishwajith; Liao, Xiaoyun; Chau, Nicole; Haddad, Robert; El-Naggar, Adel; Freeman, Gordon; Hodi, F; Rodig, Scott; Dranoff, Glenn; Schoenfeld, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunoprofiling of T cell responses in melanoma patients undergoing CPI therapy. Issue 2 (December 2015) Authors: Talarico, Lee; Grubaugh, Daniel; Yan, Zheng; Alami, Aula; Bodmer, Jean-Luc; Higgins, Darren; Hodi, F; Flechtner, Jessica Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study. Issue 1 (December 2015) Authors: Fay, André; Signoretti, Sabina; Callea, Marcella; Telό, Gabriela; McKay, Rana; Song, Jiaxi; Carvo, Ingrid; Lampron, Megan; Kaymakcalan, Marina; Poli-de-Figueiredo, Carlos; Bellmunt, Joaquim; Hodi, F; Freeman, Gordon; Elfiky, Aymen; Choueiri, Toni Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗